
Gailene Gabel
Examiner (ID: 13812, Phone: (571)272-0820 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1641, 1678, 1677 |
| Total Applications | 1469 |
| Issued Applications | 864 |
| Pending Applications | 213 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18568298
[patent_doc_number] => 20230258634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
[patent_app_type] => utility
[patent_app_number] => 17/944439
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944439
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/944439 | PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING | Sep 13, 2022 | Abandoned |
Array
(
[id] => 18643300
[patent_doc_number] => 11767360
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-09-26
[patent_title] => Elisa for diagnosis of
[patent_app_type] => utility
[patent_app_number] => 17/941212
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5298
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941212 | Elisa for diagnosis of | Sep 8, 2022 | Issued |
Array
(
[id] => 19725192
[patent_doc_number] => 20250027943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => BIOMARKER COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/684221
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18684221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/684221 | BIOMARKER COMPOSITIONS AND METHODS OF USE THEREOF | Sep 6, 2022 | Pending |
Array
(
[id] => 18094632
[patent_doc_number] => 20220412973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHODS OF ANALYSIS OF BLOOD FROM DECEASED DONORS
[patent_app_type] => utility
[patent_app_number] => 17/902102
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902102 | METHODS OF ANALYSIS OF BLOOD FROM DECEASED DONORS | Sep 1, 2022 | Abandoned |
Array
(
[id] => 18537781
[patent_doc_number] => 20230242881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PREPARATION OF FETAL NUCLEATED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTING
[patent_app_type] => utility
[patent_app_number] => 17/902095
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902095 | Preparation of fetal nucleated red blood cells (NRBCs) for diagnostic testing | Sep 1, 2022 | Issued |
Array
(
[id] => 19004853
[patent_doc_number] => 20240068924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => SPECIMEN ENRICHMENT FOR OPTICAL TOMOGRAPHY CELL ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 17/898074
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898074 | Specimen enrichment for optical tomography cell analysis | Aug 28, 2022 | Issued |
Array
(
[id] => 18037560
[patent_doc_number] => 20220381776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => BIOLOGICAL SAMPLE ANALYSIS METHOD
[patent_app_type] => utility
[patent_app_number] => 17/886044
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/886044 | BIOLOGICAL SAMPLE ANALYSIS METHOD | Aug 10, 2022 | Abandoned |
Array
(
[id] => 19717367
[patent_doc_number] => 12202890
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-21
[patent_title] => Antibodies for detection and enrichment of fetal cells and their use
[patent_app_type] => utility
[patent_app_number] => 17/818671
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 99
[patent_no_of_words] => 29586
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818671 | Antibodies for detection and enrichment of fetal cells and their use | Aug 8, 2022 | Issued |
Array
(
[id] => 18295358
[patent_doc_number] => 20230105044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => MULTI CHANNEL ISOTHERMAL AMPLIFICATION SYSTEM AND OPERATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/882835
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17882835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/882835 | MULTI CHANNEL ISOTHERMAL AMPLIFICATION SYSTEM AND OPERATION METHOD THEREOF | Aug 7, 2022 | Abandoned |
Array
(
[id] => 18195847
[patent_doc_number] => 20230049366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => CIRCULATION SYSTEM AND METHOD FOR DETECTING IMMUNE ADHERENCE OF PORCINE ERYTHROCYTES
[patent_app_type] => utility
[patent_app_number] => 17/881069
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881069 | CIRCULATION SYSTEM AND METHOD FOR DETECTING IMMUNE ADHERENCE OF PORCINE ERYTHROCYTES | Aug 3, 2022 | Abandoned |
Array
(
[id] => 18006313
[patent_doc_number] => 20220365079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => BIOLOGICAL SAMPLE ANALYSIS METHOD
[patent_app_type] => utility
[patent_app_number] => 17/874458
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874458 | BIOLOGICAL SAMPLE ANALYSIS METHOD | Jul 26, 2022 | Pending |
Array
(
[id] => 17991288
[patent_doc_number] => 20220357325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHOD FOR MEMORY B CELL-SPECIFIC DIFFERENTIATION INDUCTION, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/871775
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871775 | Method for memory B cell-specific differentiation induction, and uses thereof | Jul 21, 2022 | Issued |
Array
(
[id] => 18078737
[patent_doc_number] => 20220404349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS AND USES FOR REMOTELY TRIGGERED PROTEASE ACTIVITY MEASUREMENTS
[patent_app_type] => utility
[patent_app_number] => 17/813899
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813899
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813899 | METHODS AND USES FOR REMOTELY TRIGGERED PROTEASE ACTIVITY MEASUREMENTS | Jul 19, 2022 | Pending |
Array
(
[id] => 18710490
[patent_doc_number] => 20230333115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => KIT FOR DETECTING ANTI-PROTEASOME SUBUNIT ALPHA TYPE 1-IMMUNOGLOBULIN G (IgG) ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/856033
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856033 | KIT FOR DETECTING ANTI-PROTEASOME SUBUNIT ALPHA TYPE 1-IMMUNOGLOBULIN G (IgG) ANTIBODY | Jun 30, 2022 | Abandoned |
Array
(
[id] => 19465502
[patent_doc_number] => 20240319172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => METHODS OF ISOLATING OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/573079
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573079
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573079 | METHODS OF ISOLATING OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF | Jun 21, 2022 | Pending |
Array
(
[id] => 18816421
[patent_doc_number] => 20230390761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => Microbiology test card
[patent_app_type] => utility
[patent_app_number] => 17/803380
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17803380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/803380 | Microbiology test card | Jun 5, 2022 | Issued |
Array
(
[id] => 17868474
[patent_doc_number] => 20220291210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => ANALYSIS METHOD AND ANALYSIS DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/828177
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/828177 | ANALYSIS METHOD AND ANALYSIS DEVICE | May 30, 2022 | Abandoned |
Array
(
[id] => 18094636
[patent_doc_number] => 20220412977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => KERATIN 17 AS A BIOMARKER FOR BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/826283
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826283 | Keratin 17 as a biomarker for bladder cancer | May 26, 2022 | Issued |
Array
(
[id] => 19346540
[patent_doc_number] => 20240255503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => SCREENING FOR THE EFFECTS OF COMPLEMENT PROTEIN CHANGES
[patent_app_type] => utility
[patent_app_number] => 18/565377
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565377
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/565377 | SCREENING FOR THE EFFECTS OF COMPLEMENT PROTEIN CHANGES | May 24, 2022 | Pending |
Array
(
[id] => 19346558
[patent_doc_number] => 20240255521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => Cilia Protein as Biomarkers and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 18/561185
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561185
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561185 | Cilia Protein as Biomarkers and Methods of Use | May 19, 2022 | Pending |